Leading Research and Advisory Firm Recognizes Collexis as an Up-and-Coming Influential Player in the Scientific, Technical and Medical Information Market
COLUMBIA, SC – November 21, 2008 – Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that Outsell, Inc. has named Collexis as one of its rising stars. Outsell, the only research and advisory firm focused on the publishing, information, and education industries, recognized Collexis for its expert profiling solutions that add value through data visualization and data processing – technology that is becoming an important part of information companies’ core activities.
Collexis was recognized as one of five rising stars in the scientific, technical and medical information (STM) market based on its impact on traditional business practices through its ground-breaking technology.
“We are very pleased to be recognized as a key industry player in Outsell’s 2008 Market Forecast and Trends Report for the STM market,’ said Bill Kirkland, CEO of Collexis. “This past year we have achieved many milestones in the life sciences and health care markets. As the market leader in knowledge expert profiles and grant management tools in the sciences, Collexis is well positioned to become a leading technology solutions provider in the STM industry for years to come.” (For more information about the Outsell report visit http://outsellinc.com/store/products/772?refid=prcol)
About Outsell, Inc.
Outsell is the only research and advisory firm focused on the publishing, information, and education industries. Outsell’s international team provides independent, fact-based analysis and actionable advice about competitors, markets, operational benchmarks, and best practices, so our clients thrive and grow in today’s fast-changing digital and global environment. Outsell’s headquarters are in Burlingame, CA, US and London, UK.
For more information, visit www.outsellinc.com.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis’ proprietary technology builds conceptual profiles of text, called “Fingerprints”, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “Fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’ current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB).
For more information, visit www.collexis.com.
Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties. These risks and uncertainties are in addition to other factors detailed from time to time in the company’s filings with the SEC, including the section entitled “Risk Factors” in its transition report on Form 10-KSB for the period ended June 30, 2008. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.